These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6158597)

  • 1. [Selective staining of T-lymphoblastic leukemia cells by glycyl-prolyl-4-methoxy-beta-naphthylamiden-peptidase (DAP IV) (author's transl)].
    Feller AC; Parwaresch MR
    Klin Padiatr; 1980 Mar; 192(2):150-3. PubMed ID: 6158597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymehistochemical staining of T mu lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV).
    Feller AC; Heijnen CJ; Ballieux RE; Parwaresch MR
    Br J Haematol; 1982 Jun; 51(2):227-34. PubMed ID: 6123345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
    Feller AC; Parwaresch MR; Lennert K
    Leuk Res; 1984; 8(3):397-406. PubMed ID: 6379309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of dipeptidyl peptidase IV from lymphocytes of chronic lymphocytic leukemia of T-type.
    Mentlein R; Rix H; Feller AC; Heymann E
    Biomed Biochim Acta; 1986; 45(5):567-74. PubMed ID: 2875712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochemistry of dipeptidylaminopeptidase IV in T lymphoblastic leukaemia-lymphoma.
    Invernizzi R; Perugini O; De Fazio P; Bonetti F; Nespoli BL
    Haematologia (Budap); 1989; 22(3):143-9. PubMed ID: 2573567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase IV in human T-lymphocytes: cytochemical and histochemical investigations in patients with non-Hodgkin's lymphoma.
    Schön E; Essbach U; Machura R; Franke A; Ansorge S
    Acta Histochem Suppl; 1986; 33():131-8. PubMed ID: 2874587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
    Feller AC; Parwaresch MR; Bartels H; Lennert K
    Leuk Res; 1982; 6(6):801-8. PubMed ID: 6759796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV activity in cells of T-lymphoid origin is decreased in cultures with 12-0-tetradecanoylphorbol-13-acetate (TPA).
    Lemez P; Koubek K; Malasková V; Lojda Z
    Haematologia (Budap); 1987; 20(3):165-70. PubMed ID: 2891591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
    Sterry W; Steigleder GK; Goos M; Meisterernst E
    Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
    Andrews C; Crockard AD; San Miguel JF; Catovsky D
    Clin Lab Haematol; 1985; 7(4):359-68. PubMed ID: 2869856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.
    Khalaf MR; Bevan PC; Hayhoe FG
    J Clin Pathol; 1986 Aug; 39(8):891-6. PubMed ID: 2875085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphoblastic lymphomas in children. Their recognizability as T- or B-cell neoplasms in histologic slides (routine sections) (author's transl)].
    Schwarze EW; Pileri S; Tolksdorf G; Kampert-Blumberg J
    Klin Padiatr; 1981 May; 193(3):131-6. PubMed ID: 6973667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl(amino)peptidase IV (DAP-IV) histochemistry on normal and pathologic lymphoid tissues.
    Chilosi M; Pizzolo G; Menestrina F; Iannucci AM; Bonetti F; Fiore-Donati L
    Am J Clin Pathol; 1982 Jun; 77(6):714-9. PubMed ID: 7046417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.
    Ahmad S; Wang L; Ward PE
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1257-61. PubMed ID: 1372050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)].
    Ritter J; Gaedicke G; Winkler K; Landbeck G
    Z Kinderheilkd; 1975 Sep; 120(3):211-5. PubMed ID: 1080934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dipeptidyl peptidase IV of peripheral blood lymphocytes in patients with primary biliary cirrhosis].
    Adler D; Kürktschiev D; Subat S; Lehmann HU; Schentke KU
    Z Gastroenterol; 1993 Feb; 31(2):135-9. PubMed ID: 8096665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
    Feller AC; Parwaresch MR; Lennert K
    Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
    Crockard AD; MacFarlane E; Andrews C; Bridges JM; Catovsky D
    Am J Clin Pathol; 1984 Sep; 82(3):294-9. PubMed ID: 6380269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.